Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/30/2026

1. NTAP
2. SPY
3. MDB
4. FFAI
5. NVDA
6. META
7. AIR
8. ORCL
9. MTN
10. SMMT

Go back to Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.82 +0.02 (0.19%)
Previous Close $10.80    52 Week High $9.23 
Open $10.80    52 Week Low $1.16 
Day High $11.11    P/E N/A 
Day Low $10.41    EPS $-0.30 
Volume 4,070,436